Second transaction this year in the orthopedic sector for Potomac, advising on the sale of Teknimed, a leader in biomaterials, to the private equity firm Essling Capital


Founded in 1990 in Toulouse (France), the European capital of aeronautics, Teknimed is a leader in biomaterials with a unique expertise in orthopedic cements used to fix implants such as hips, knees, shoulders, etc.

Teknimed develops, manufactures and markets worldwide a full and innovative biomaterial product portfolio for orthopedic surgeries and sports medicine. The portfolio includes orthopedic cements, bone substitutes, resorbable polymers and implantable textiles.

After the intra-family transaction in 2015 between Alain Leonard and his daughter Carole financed by the Apax, BPI and Crédit Mutuelle investment funds, Essling Capital is taking over control of Teknimed alongside its CEO, Carole Leonard.

With a unique expertise in biomaterials and a solid growing market, the strategy is to accelerate the international development as well as the development of the OEM business, organically and by acquisitions.